Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
TEVA

TEVA PHARMACEUTICAL INDUSTRIES (TEVA) stock: insider trades, news & valuation

Heavy selling
Close · Oct 9, 2026 $41.10 +4.7% on the day +105.1% over 12 months 52-week range $18.95 – $41.10

Share price and insider trades

TEVA closeInsider buyInsider sale
1020304050NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $593 on 2026-08-05 · Tal Zvi ZaksSold $211,356 on 2026-06-05 · Richard D FrancisSold $321,546 on 2026-06-18 · Matthew ShieldsSold $370,735 on 2026-08-21 · Amir Weiss, Ronit Satchi-fainaroSold $384,444 on 2026-05-06 · Amir WeissSold $532,330 on 2026-06-03 · Matthew ShieldsSold $680,202 on 2026-08-17 · Evan LippmanSold $699,515 on 2025-11-20 · Christine FoxSold $750,620 on 2026-04-30 · Christine FoxSold $753,300 on 2025-11-14 · Christine FoxSold $1,062,000 on 2026-05-05 · Richard DaniellSold $1,301,500 on 2025-11-26 · Roberto MignoneSold $1,339,566 on 2026-08-03 · Eric A Hughes, Placid JoverSold $1,871,754 on 2026-03-17 · Mark SabagSold $2,712,036 on 2025-12-16 · Amir Weiss, Roberto MignoneSold $2,766,343 on 2026-03-05 · Brian Savage, Christine Fox, Eric A Hughes, Matthew Shields, Placid Jover, Richard D Francis, Richard DaniellSold $3,633,798 on 2026-06-11 · Eliyahu Sharon KalifSold $4,490,911 on 2026-03-04 · Brian Savage, Christine Fox, Eric A Hughes, Richard D Francis, Richard DaniellSold $5,044,858 on 2026-05-01 · Mark SabagSold $5,122,612 on 2025-11-06 · Amir Weiss, Roberto MignoneSold $6,939,460 on 2026-05-14 · Eliyahu Sharon Kalif, Evan LippmanSold $9,542,359 on 2025-12-09 · Mark Sabag, Richard DaniellSold $11,633,048 on 2026-02-26 · Eliyahu Sharon KalifSold $14,643,683 on 2026-09-18 · Brian Savage, Roberto MignoneSold $15,322,963 on 2026-02-15 · Richard D FrancisSold $21,162,016 on 2026-03-03 · Brian Savage, Eric A Hughes, Richard D Francis, Richard Daniell
Bought, 12 months$0
Sold, 12 months$113M
Insiders buying0
Insiders selling14

TEVA PHARMACEUTICAL INDUSTRIES insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 14 sold $113M of TEVA stock on the open market.

TEVA insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $20.1M sold (10 trades)Q4 2025Q1 2026: $57.2M sold (26 trades)Q1 2026Q2 2026: $18.9M sold (11 trades)Q2 2026Q3 2026: $17.0M sold (11 trades)Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0$17.0M11
Q2 2026—0$18.9M11
Q1 2026—0$57.2M26
Q4 2025—0$20.1M10

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day1.2×Last 5 sessions
Insiders' paper profit—On all tracked purchases —

Summary

Over the past 12 months, 0 TEVA PHARMACEUTICAL INDUSTRIES LTD insiders reported open-market purchases totaling $0, while 14 insiders reported sales totaling $113M. 31 of 58 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Members of Congress who traded TEVA

From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.

All Congress trades →
MemberTradeTradedReportedSince trade
Alan ArmstrongSenate Bought $1,001 - $15,000 Mar 30, 2026Jul 21, 2026 +45.0%

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Sep 22SEC Roberto MignoneDirector Sell 367,600 $39.06 $14.4M +5.2% —
Sep 22SEC Brian SavageGeneral Counsel Sell 4,50311,339 held (−28%) $38.69 $174K +6.2% —
Sep 22SEC Brian SavageGeneral Counsel Sell 2,5258,814 held (−22%) $39.15 $99K +5.0% —
Sep 22SEC Brian SavageGeneral Counsel Sell 3148,500 held (−4%) $38.70 $12K +6.2% —
Aug 25SEC Amir WeissChief Accounting Officer Sell 6,94513,071 held (−35%) $37.61 $261K +9.3% —
Aug 25SEC Amir WeissChief Accounting Officer Sell 2,50013,071 held (−16%) $37.63 $94K +9.2% —
Aug 25SEC Ronit Satchi-fainaroDirector Sell 415111,986 held (−0%) $37.25 $15K +10.3% —
Aug 19SEC Evan LippmanEvp, Business Development Sell Plan 18,60025,591 held (−42%) $36.57 $680K +12.4% —
Aug 10SEC Tal Zvi ZaksDirector Sell 1773,247 held (−0%) $34.87 $593 +17.9% —
Aug 5SEC Eric A Hughes"See ""Remarks""" Sell Plan 25,578134,877 held (−16%) $34.88 $892K +17.8% —
Aug 5SEC Placid Jover"See ""Remarks""" Sell Plan 12,8276,774 held (−65%) $34.88 $447K +17.8% —
Jun 22SEC Matthew ShieldsEvp, Global Operations Sell 9,989 $32.19 $322K +27.7% —
Jun 16SEC Eliyahu Sharon KalifCFO Sell Plan 106,56365,621 held (−62%) $34.10 $3.6M +20.5% —
Jun 8SEC Richard D FrancisCEO, President Sell Plan 6,1531,177,529 held (−1%) $34.35 $211K +19.7% —
Jun 4SEC Matthew ShieldsEvp, Global Operations Sell Plan 16,1959,989 held (−62%) $32.87 $532K +25.0% —
May 18SEC Eliyahu Sharon KalifCFO Sell Plan 153,251172,184 held (−47%) $35.61 $5.5M +15.4% —
May 18SEC Evan LippmanEvp, Business Development Sell Plan 35,91244,191 held (−45%) $35.58 $1.3M +15.5% —
May 18SEC Evan LippmanEvp, Business Development Sell Plan 5,7466,095 held (−49%) $35.58 $204K +15.5% —
May 7SEC Richard DaniellEvp, Europe Commercial Sell 30,00055,755 held (−35%) $35.40 $1.1M +16.1% —
May 7SEC Amir WeissChief Accounting Officer Sell 10,67920,016 held (−35%) $36.00 $384K +14.2% —
May 4SEC Mark Sabag"See ""Remarks""" Sell 144,18080,760 held (−64%) $34.99 $5.0M +17.5% —
May 4SEC Christine FoxEvp, U.S. Commercial Sell 21,25863,647 held (−25%) $35.31 $751K +16.4% —
Mar 19SEC Mark Sabag"See ""Remarks""" Sell 62,102224,940 held (−22%) $30.14 $1.9M +36.4% —
Mar 9SEC Richard D FrancisCEO, President Sell Plan 20,0251,170,639 held (−2%) $31.67 $634K +29.8% —
Mar 9SEC Richard DaniellEvp, Europe Commercial Sell Plan 17,29585,755 held (−17%) $31.67 $548K +29.8% —
Mar 9SEC Matthew ShieldsEvp, Global Operations Sell Plan 17,2959,989 held (−63%) $31.67 $548K +29.8% —
Mar 9SEC Placid Jover"See ""Remarks""" Sell Plan 14,1506,774 held (−68%) $31.67 $448K +29.8% —
Mar 9SEC Eric A Hughes"See ""Remarks""" Sell Plan 9,533107,711 held (−8%) $31.67 $302K +29.8% —
Mar 9SEC Christine FoxEvp, U.S. Commercial Sell Plan 7,92484,905 held (−9%) $31.67 $251K +29.8% —
Mar 9SEC Brian SavageGeneral Counsel Sell 1,12710,914 held (−9%) $31.67 $36K +29.8% —
Mar 6SEC Richard DaniellEvp, Europe Commercial Sell Plan 37,37285,755 held (−30%) $32.95 $1.2M +24.7% —
Mar 6SEC Richard DaniellEvp, Europe Commercial Sell Plan 33,512123,127 held (−21%) $32.46 $1.1M +26.6% —
Mar 6SEC Richard D FrancisCEO, President Sell Plan 23,3931,148,212 held (−2%) $32.46 $759K +26.6% —
Mar 6SEC Richard DaniellEvp, Europe Commercial Sell Plan 20,461123,127 held (−14%) $32.46 $664K +26.6% —
Mar 6SEC Eric A Hughes"See ""Remarks""" Sell Plan 11,27797,590 held (−10%) $32.46 $366K +26.6% —
Mar 6SEC Christine FoxEvp, U.S. Commercial Sell Plan 9,09875,010 held (−11%) $32.46 $295K +26.6% —
Mar 6SEC Brian SavageGeneral Counsel Sell 1,4896,181 held (−19%) $32.46 $48K +26.6% —
Mar 6SEC Brian SavageGeneral Counsel Sell 1,1868,461 held (−12%) $32.46 $38K +26.6% —
Mar 5SEC Richard D FrancisCEO, President Sell Plan 412,0321,121,382 held (−27%) $32.36 $13.3M +27.0% —
Mar 5SEC Eric A Hughes"See ""Remarks""" Sell Plan 68,68585,616 held (−45%) $32.36 $2.2M +27.0% —
Mar 5SEC Richard DaniellEvp, Europe Commercial Sell Plan 66,735123,127 held (−35%) $32.36 $2.2M +27.0% —
Mar 5SEC Richard DaniellEvp, Europe Commercial Sell Plan 62,25048,384 held (−56%) $32.36 $2.0M +27.0% —
Mar 5SEC Richard D FrancisCEO, President Sell Plan 30,903642,099 held (−5%) $32.36 $1.0M +27.0% —
Mar 5SEC Eric A Hughes"See ""Remarks""" Sell Plan 12,07712,823 held (−49%) $32.36 $391K +27.0% —
Mar 5SEC Brian SavageGeneral Counsel Sell 1,2742,926 held (−30%) $32.36 $41K +27.0% —
Mar 2SEC Eliyahu Sharon KalifCFO Sell Plan 345,81057,478 held (−86%) $33.64 $11.6M +22.2% —
Feb 18SEC Richard D FrancisCEO, President Sell Plan 286,122605,771 held (−32%) $34.22 $9.8M +20.1% —
Feb 18SEC Richard D FrancisCEO, President Sell Plan 161,656271,783 held (−37%) $34.22 $5.5M +20.1% —
Dec 18SEC Roberto MignoneDirector Sell 77,400367,600 held (−17%) $30.24 $2.3M +35.9% —
Dec 18SEC Amir WeissChief Accounting Officer Sell 12,3005,650 held (−69%) $30.20 $371K +36.1% —
Dec 11SEC Mark Sabag"See ""Remarks""" Sell 118,724150,996 held (−44%) $28.75 $3.4M +43.0% —
Dec 11SEC Richard DaniellExec. Vp, European Commercial Sell 115,46848,384 held (−70%) $28.68 $3.3M +43.3% —
Dec 11SEC Mark Sabag"See ""Remarks""" Sell 98,16852,828 held (−65%) $28.70 $2.8M +43.2% —
Dec 1SEC Roberto MignoneDirector Sell 50,000445,000 held (−10%) $26.03 $1.3M +57.9% —
Nov 24SEC Christine FoxEvp, Head Of U.S. Commercial Sell Plan 28,22963,647 held (−31%) $24.78 $700K +65.9% —
Nov 18SEC Christine FoxEvp, Head Of U.S. Commercial Sell 30,00028,384 held (−51%) $25.11 $753K +63.7% —
Nov 10SEC Roberto MignoneDirector Sell 200,000495,000 held (−29%) $24.11 $4.8M +70.5% —
Nov 10SEC Amir WeissChief Accounting Officer Sell 12,30017,950 held (−41%) $24.44 $301K +68.2% —

Insiders at TEVA PHARMACEUTICAL INDUSTRIES LTD

InsiderBoughtSoldLast filingScore
Richard D FrancisCEO, President — $31.3M Jun 8, 2026 —
Roberto MignoneDirector — $22.8M Sep 22, 2026 —
Eliyahu Sharon KalifCFO — $20.7M Jun 16, 2026 —
Mark Sabag"See ""Remarks""" — $13.1M May 4, 2026 —
Richard DaniellEvp, Europe Commercial — $12.1M May 7, 2026 —
Eric A Hughes"See ""Remarks""" — $4.2M Aug 5, 2026 —
Christine FoxEvp, U.S. Commercial — $2.7M May 4, 2026 —
Evan LippmanEvp, Business Development — $2.2M Aug 19, 2026 —
Amir WeissChief Accounting Officer — $1.4M Aug 25, 2026 —
Matthew ShieldsEvp, Global Operations — $1.4M Jun 22, 2026 —
Placid Jover"See ""Remarks""" — $896K Aug 5, 2026 —
Brian SavageGeneral Counsel — $449K Sep 22, 2026 —
Ronit Satchi-fainaroDirector — $15K Aug 25, 2026 —
Tal Zvi ZaksDirector — $593 Aug 10, 2026 —

TEVA stock: common questions

Are TEVA PHARMACEUTICAL INDUSTRIES LTD insiders buying TEVA stock?

In the past 12 months, 0 insiders reported open-market purchases of TEVA worth $0.

Are TEVA PHARMACEUTICAL INDUSTRIES LTD insiders selling TEVA stock?

14 insiders reported sales worth $113M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is TEVA's 52-week range?

Over the past year TEVA has traded between $18.95 and $41.10. It last closed at $41.10 on Oct 9, 2026.